ID
14798
Beskrivning
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT00754325
Länk
https://clinicaltrials.gov/show/NCT00754325
Nyckelord
Versioner (1)
- 2016-04-28 2016-04-28 -
Uppladdad den
28 april 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Advanced Breast Cancer NCT00754325
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beskrivning
pregnant or breast feeding
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Beskrivning
chemotherapy regimen
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0392920
Beskrivning
pleural or pericardial effusion
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0032227
- UMLS CUI [2]
- C0031039
Beskrivning
cardiac condition
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0018799
Similar models
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
C0232970 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0031039 (UMLS CUI [2])